Fc-gamma Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer
Geoffrey Liu, Dongsheng Tu, Marcia Lewis, Dangxiao Cheng, Leslie A Sullivan, Zhuo Chen, Eric Morgen, John Simes, Timothy J Price, Niall C Tebbutt, Jeremy D Shapiro, G Mark Jeffery, J Daniel Mellor, Thomas Mikeska, Shakeel Virk, Lois E Shepherd, Derek J Jonker, Christopher J O'Callaghan, John R Zalcberg, Christos S Karapetis Show all
Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2016
This research was supported by an OICR High Impact Clinical Trial Small Project Grant and by an unrestricted grant from Transgenomic, Inc. G. Liu was supported by the Alan B. Brown Chair in Molecular Genomics and the Cancer Care Ontario Chair in Experimental Therapeutics and Population Studies, E. Morgen was supported by a CIHR Banting and Best Canada Graduate Scholarship, and J.D. Mellor was supported by a grant from the Peter MacCallum Cancer Centre Research Foundation. This work was also supported by the NCIC Clinical Trials Group Tumour Tissue Data Repository (TTDR). The NCIC CTG TTDR is a member of the Canadian Tumour Repository Network.